166 related articles for article (PubMed ID: 10699942)
1. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma.
Hjalgrim H; Frisch M; Storm HH; Glimelius B; Pedersen JB; Melbye M
Int J Cancer; 2000 Mar; 85(5):639-42. PubMed ID: 10699942
[TBL] [Abstract][Full Text] [Related]
2. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
3. Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?
Askling J; Sørensen P; Ekbom A; Frisch M; Melbye M; Glimelius B; Hjalgrim H
Ann Intern Med; 1999 Nov; 131(9):655-9. PubMed ID: 10577327
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
5. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
Lens MB; Newton-Bishop JA
Ann Oncol; 2005 Mar; 16(3):460-5. PubMed ID: 15642704
[TBL] [Abstract][Full Text] [Related]
6. Mortality in cancer patients with a history of cutaneous squamous cell carcinoma--a nationwide population-based cohort study.
Johannesdottir SA; Lash TL; Jensen AØ; Farkas DK; Olesen AB
BMC Cancer; 2012 Mar; 12():126. PubMed ID: 22458954
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
[TBL] [Abstract][Full Text] [Related]
8. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.
Levi F; Randimbison L; Te VC; La Vecchia C
Br J Cancer; 1996 Dec; 74(11):1847-50. PubMed ID: 8956805
[TBL] [Abstract][Full Text] [Related]
10. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden.
Adami J; Gridley G; Nyrén O; Dosemeci M; Linet M; Glimelius B; Ekbom A; Zahm SH
Int J Cancer; 1999 Mar; 80(5):641-5. PubMed ID: 10048959
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
12. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
Hemminki K; Jiang Y; Steineck G
Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
[TBL] [Abstract][Full Text] [Related]
13. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study.
Freedman DM; Zahm SH; Dosemeci M
BMJ; 1997 May; 314(7092):1451-5. PubMed ID: 9167561
[TBL] [Abstract][Full Text] [Related]
14. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
15. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma and skin malignancies--shared etiology?
Hall P; Rosendahl I; Mattsson A; Einhorn S
Int J Cancer; 1995 Sep; 62(5):519-22. PubMed ID: 7665220
[TBL] [Abstract][Full Text] [Related]
18. Sebaceous carcinoma in the clinical setting of non-Hodgkin lymphoma: the Mayo Clinic experience.
Chang TW; Weaver AL; Brewer JD
Int J Dermatol; 2013 Oct; 52(10):1210-4. PubMed ID: 23675639
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]